This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor | MicrobiomeTrials
← Back to trials NCT04616560
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2021-03-08Est. Completion: 2027-12-31
Enrollment target: 55 participantsLocations Children's Hospital of Alabama, Birmingham, Alabama, United States Children's Hospital Los Angeles, Los Angeles, California, United States Children's Hospital of Orange County, Orange, California, United States Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States UCSF Medical Center-Mission Bay, San Francisco, California, United States Children's Hospital Colorado, Aurora, Colorado, United States Children's National Medical Center, Washington D.C., District of Columbia, United States Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States Lurie Children's Hospital-Chicago, Chicago, Illinois, United States University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States Riley Hospital for Children, Indianapolis, Indiana, United States Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States Dana-Farber Cancer Institute, Boston, Massachusetts, United States Other microbiome trials you might be interested in Sarcoma Desmoplastic Small Round Cell Tumor (DSRCT)
This study adds irinotecan, temozolomide and bevacizumab to the chemotherapy regimen currently used to treat Desmoplasti…
New York, United States Est. completion Aug 2027
Ewing Sarcoma Desmoplastic Small Round Cell Tumor Pediatric Cancer Undifferentiated Sarcoma
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at trea…
Los Angeles, United States
C S Mott Children's Hospital, Ann Arbor, Michigan, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
Primary Children's Hospital, Salt Lake City, Utah, United States Est. completion Jul 30, 2028